glp 1 drugs kidney disease Glucagon-like peptide-1 receptor agonists in diabetic disease: A review of their kidney and heart protection Glucagon-Like Peptide-1 Receptor Agonist Use

First in Human Clinical trials (FIH trials) play a critical role in bringing investigational new drugs or interventions to the clinical practice

*Correspondence: Liang Guo, [email protected] Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers

Prospective Analysis on the Effect of Botanical Medicine (Tribulus terrestris) on Serum Testosterone Level and Semen Parameters in Males with Unexplained Infertility

Factors affecting results Multiple factors influence wolverine stack outcomes

L.DonaldsonJ.CummingS

This study evaluated the individual and combinatorial effects of both Zn (1, 2, 3, 4, and 5 mg L 1 Hoagland solution) and NaCl (150 and 200 mM NaCl) treatments on the various morpho-physiological and biochemical parameters of Setaria italica